BACKGROUND: Adipose tissue provides an easily accessible and abundant source of putative stem cells for translational clinical research. Currently prevalent culture techniques include the use of FBS, a highly variable and undefined component, which brings with it the potential for adverse patient reactions. In an effort to eliminate the use of animal products in human adipose stem cell (ASC) cultures, we have developed two new culture methods, a very low human serum expansion medium and a completely serum-free medium. METHODS: Through serial testing, a highly enriched medium formulation was developed for use with and without the addition of 0.5% human serum, an amount easily obtainable from autologous blood draws. RESULTS: Very low-serum culture yielded population-doubling times averaging 1.86 days in early passage, while the serum-free formulation was associated with less robust cell growth, with doubling times averaging 5.79 days. ASC in both conditions maintained its ability to differentiate into adipo-, chondro- and osteogenic lineages in vitro, despite lower expression of CD34 in early passage. Expression of ALDH, HLA, CD133, CD184, and CD31 was comparable with that seen in cells cultured in 10% FBS. DISCUSSION: These newly developed culture conditions provide a unique environment within which to study ASCs without the interference of animal serum, and allow for the rapid expansion of autologous ASCs in culture in an animal product-free environment for use in human clinical trials.
BACKGROUND: Adipose tissue provides an easily accessible and abundant source of putative stem cells for translational clinical research. Currently prevalent culture techniques include the use of FBS, a highly variable and undefined component, which brings with it the potential for adverse patient reactions. In an effort to eliminate the use of animal products in human adipose stem cell (ASC) cultures, we have developed two new culture methods, a very low human serum expansion medium and a completely serum-free medium. METHODS: Through serial testing, a highly enriched medium formulation was developed for use with and without the addition of 0.5% human serum, an amount easily obtainable from autologous blood draws. RESULTS: Very low-serum culture yielded population-doubling times averaging 1.86 days in early passage, while the serum-free formulation was associated with less robust cell growth, with doubling times averaging 5.79 days. ASC in both conditions maintained its ability to differentiate into adipo-, chondro- and osteogenic lineages in vitro, despite lower expression of CD34 in early passage. Expression of ALDH, HLA, CD133, CD184, and CD31 was comparable with that seen in cells cultured in 10% FBS. DISCUSSION: These newly developed culture conditions provide a unique environment within which to study ASCs without the interference of animal serum, and allow for the rapid expansion of autologous ASCs in culture in an animal product-free environment for use in human clinical trials.
Authors: Wan Kamarul Zaman Wan Safwani; Chin Wei Wong; Kar Wey Yong; Jane Ru Choi; Noor Azmi Mat Adenan; Siti Zawiah Omar; Wan Abu Bakar Wan Abas; Belinda Pingguan-Murphy Journal: Cytotechnology Date: 2016-01-04 Impact factor: 2.058
Authors: Peter J Amos; Sahil K Kapur; Peter C Stapor; Hulan Shang; Stefan Bekiranov; Moshe Khurgel; George T Rodeheaver; Shayn M Peirce; Adam J Katz Journal: Tissue Eng Part A Date: 2010-05 Impact factor: 3.845
Authors: Bettina Lindroos; Kaisa-Leena Aho; Hannu Kuokkanen; Sari Räty; Heini Huhtala; Riina Lemponen; Olli Yli-Harja; Riitta Suuronen; Susanna Miettinen Journal: Tissue Eng Part A Date: 2010-07 Impact factor: 3.845
Authors: Szu-Yu Chen; Megha Mahabole; Elan Horesh; Sara Wester; Jeffrey L Goldberg; Scheffer C G Tseng Journal: Invest Ophthalmol Vis Sci Date: 2014-07-03 Impact factor: 4.799
Authors: Lauren S Sefcik; Rebekah A Neal; Stephanie N Kaszuba; Anna M Parker; Adam J Katz; Roy C Ogle; Edward A Botchwey Journal: J Tissue Eng Regen Med Date: 2008-06 Impact factor: 3.963
Authors: Jani Pelto; Miina Björninen; Aliisa Pälli; Elina Talvitie; Jari Hyttinen; Bettina Mannerström; Riitta Suuronen Seppanen; Minna Kellomäki; Susanna Miettinen; Suvi Haimi Journal: Tissue Eng Part A Date: 2013-01-04 Impact factor: 3.845